Tell some scientists in the United States nature They are considering leaving the country following a widespread disruption of the research brought by the administration of US President Donald Trump. The researchers say they are looking for opportunities in Europe, Australia and Asia.
Since Trump took office in January, his administration has reduced thousands of jobs in public health and science agencies, and the financing of frozen biomedical research, and the money has been reduced to cover the costs of research and grants that are not in line with management priorities. The researchers felt all over the United States and outside the effects of these changes.
“I was really enthusiastic about my work, but the situation in the United States is very stressful,” says post -doctoral researcher at a prestigious American institution. The researcher from South Asia but has spent the past four years in the United States, and is now talking to colleagues in Europe about opportunities. As a person who is not an American citizen, she is worried about media reports describing the Trump administration plans to enter a travel ban that affects specific countries.
Are you a researcher in the United States thinking about leaving the country? Are you planning? We want to hear from you.
Madehukar Pai, TB Researcher at McGill University in Montreal, Canada, says that US colleagues were in contact with work, or they want to speak. “The distress is very clear and sad to see it,” he says.
Ready
The prominent researcher of infectious doses, a dual citizen of the United States and a member of the European Union, intends to return to Europe in the coming months. This is the first time in the decade and a half since he moved to the United States, as he is seriously considering job offers from colleagues throughout the Atlantic Ocean. The researcher, who wants to remain unidentified, says that his plans have not been completed.
He says that the reasons for his departure include rhetorical changes to science in Trump and leadership changes in major government agencies. It also worries the future of financing in the field of infectious diseases and virus.
He says that leaving the United States will require concessions. He says salaries in Europe are generally lower than those of researchers who have experience in the United States, and the research environment in Europe can be less multidisciplinary. Science financing remains across Europe stagnant. He adds that the presence of the departure option puts it in a “very distinct position”.